A Troubling Picture For Drugmakers

BMI View: While Venezuela's increasingly harsh pricing regime looks unlikely to address persistent medicine shortages, President Hugo Chavez's renewed attempts to regulate the country's pharmaceutical sector confirm our long-standing view that Venezuela's fiscal, and to a larger extent political, trajectory present a considerable roadblock for drugmakers looking to make new investments.

To read the full article, please choose one of the following options: